Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Merck
Boehringer Ingelheim
Harvard Business School
McKinsey

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LUNESTA

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Lunesta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00235508 Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder Completed Sunovion Phase 4 2005-06-01 To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will receive an approved anxiolytic agent and will be randomized to nightly therapy with either eszopiclone or placebo.
NCT00283790 Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo Completed Sanofi Phase 4 2006-01-01 Investigation of Psychomotor and Cognitive Residual Effects of Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopiclone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Flurazepam 30 mg as an External Comparator
NCT00365261 Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer Completed University of California, San Diego Phase 4 2006-09-01 To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will: - improve sleep thereby decreasing need for opiates via PCA - improve sleep thereby decreasing pain by self report - improve sleep thereby decreasing fatigue by self report
NCT00374192 The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women Completed Sunovion N/A 2006-02-01 To examine the change in sleep patterns and mood symptoms in response to eszopiclone (Lunesta) using a double-blind placebo-controlled cross-over study design in perimenopausal and postmenopausal women who experience insomnia, mild depression and/or anxiety.
NCT00374192 The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women Completed Massachusetts General Hospital N/A 2006-02-01 To examine the change in sleep patterns and mood symptoms in response to eszopiclone (Lunesta) using a double-blind placebo-controlled cross-over study design in perimenopausal and postmenopausal women who experience insomnia, mild depression and/or anxiety.
NCT00374556 Insomnia and Osteoarthritis Study Completed Johns Hopkins University N/A 2006-01-01 This research is being done to evaluate the effects of a sleeping pill (eszopiclone, Lunesta)in patients with arthritis of the knee who also suffer from chronic insomnia. This study will test whether Lunesta improves sleep, pain sensitivity, and daytime symptoms in patients with knee pain.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lunesta

Condition Name

Condition Name for Lunesta
Intervention Trials
Insomnia 8
Primary Insomnia 4
Healthy 3
Obstructive Sleep Apnea 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lunesta
Intervention Trials
Sleep Initiation and Maintenance Disorders 13
Sleep Apnea Syndromes 3
Sleep Apnea, Obstructive 3
Apnea 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lunesta

Trials by Country

Trials by Country for Lunesta
Location Trials
United States 41
India 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lunesta
Location Trials
Massachusetts 6
California 4
Connecticut 2
Ohio 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lunesta

Clinical Trial Phase

Clinical Trial Phase for Lunesta
Clinical Trial Phase Trials
Phase 4 12
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lunesta
Clinical Trial Phase Trials
Completed 16
Terminated 2
Active, not recruiting 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lunesta

Sponsor Name

Sponsor Name for Lunesta
Sponsor Trials
Sunovion 10
Brigham and Women's Hospital 3
Dr. Reddy's Laboratories Limited 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lunesta
Sponsor Trials
Other 17
Industry 15
NIH 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson
Mallinckrodt
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.